IRCT201303287373N4CompletedPhase 2
The efficacy of anti – toxoplasma drugs in the treatment of schizophrenia , a triple – blind, randomized , placebo-controlled clinical trial
Conditions
Trial Snapshot
- Phase
- Phase 2
- Status
- Completed
- Enrollment
- 200
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 15 years to 55 years (—)
- Sex
- All
Inclusion Criteria
- •Inclusion criteria :informed written consent ;diagnosis of schizophrenia according to DSMIV _TR criteria and clinical interview by psychiatrist ;a score of at least 60 in PANSS;age range 15-55
- •Exclusion criteria: pregnancy ; lactation ;substance abuse; severe physical disease ; contraindication of cotrimoxazole
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Not yet recruiting
Unknown
Assessment of Toxoplasma gondii Seropositivity and its association with lifetime Suicidality in patients with Bipolar DisorderCTRI/2023/12/060624AIIMS NEW DELHI
Completed
Phase 3
Effect of Specific Anti-Toxoplasmatic Add-on Medication in Toxoplasma Gondii Seropositive Individuals With Schizophrenia or Major DepressionMajor DepressionSchizophreniaNCT00300404Zentrum für Integrative Psychiatrie40
Not yet recruiting
Not Applicable
To check prevalence of Toxoplasma gondii,a parasitic infection in healthy voluntary blood donors using a serological test amongst people from south-west coastal KarnatakaCTRI/2020/04/024909Kasturba Medical College Manipal
Active, not recruiting
Not Applicable
The efficacy and safety of co-trimoxazole therapy in patients with idiopathic interstitial pneumonia - TIPACIdiopathic Interstitial PneumoniaMedDRA version: 9.1Level: LLTClassification code 10022619Term: Interstitial pulmonary fibrosisEUCTR2007-002324-15-GBniversity of East Anglia
Completed
Phase 4
Evaluation of the efficacy of Tetonal drug in comparison with Meloxicam on pain relief and functional improvent of patient with knee osteoartheritisKnee osteoartheritis.IRCT20191031045291N1Shiraz university of medical sciences30
